Graft Polymer (UK) Plc plans to rebrand as Solvonis Therapeutics Plc, aligning its identity with a strategic focus on mental health and substance use disorder treatments. The company highlights ...
Graft Polymer (UK) PLC (LSE:GPL) has announced encouraging initial findings from a pre-clinical study of AW21003, a compound being developed with Awakn Life Sciences to treat trauma-related mental ...
Graft Polymer (UK) PLC (GB:GPL) has released an update. Graft Polymer (UK) Plc plans to rebrand as Solvonis Therapeutics Plc, aligning its identity with a strategic focus on mental health and ...